| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 03/09/2005 | EP1511722A1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof |
| 03/09/2005 | EP1511716A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 03/09/2005 | EP1511507A1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 03/09/2005 | EP1511504A1 Anti-helicobacter activity of celery seed extract |
| 03/09/2005 | EP1511502A2 Probiotic therapies using lactobacillus reuteri |
| 03/09/2005 | EP1511499A2 Immunomodulatory compounds and methods of use thereof |
| 03/09/2005 | EP1511488A2 Human adam-10 inhibitors |
| 03/09/2005 | EP1511482A1 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections |
| 03/09/2005 | EP1511473A2 Bis-aromatic alkanols |
| 03/09/2005 | EP1511472A2 Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 03/09/2005 | EP1511379A1 Prevention or treatment of abnormal lipoprotein, cholestasis and atherosclerosis |
| 03/09/2005 | EP1202969B1 Biphenyl derivatives, production thereof and use as medicines |
| 03/09/2005 | EP1194154B1 Use of propionic bacteria for producing propionic acid and/or propionates in the colon |
| 03/09/2005 | EP1140112B1 Etherlysophospholipids for the treatment of chronic inflammatory diseases |
| 03/09/2005 | EP1137423B1 Oral administration of lactobacillus for the treatment and prevention of urogenital infection |
| 03/09/2005 | EP1126849B1 Heterocyclic potassium channel inhibitors |
| 03/09/2005 | EP0944645B1 INHIBITORS OF INTERLEUKIN-1beta CONVERTING ENZYME |
| 03/09/2005 | CN1592747A Diazabicyclo alkane derivatives with NK1 antagonistic activity |
| 03/09/2005 | CN1592746A LFA-1 antagonist compounds |
| 03/09/2005 | CN1592745A Therapeutic chromone compounds |
| 03/09/2005 | CN1592744A Thiazole derivatives having CB1-antagonistic, agonistic or partial agonistic activity |
| 03/09/2005 | CN1592739A Novel piperidine based MCH antagonists for treatment of obesity and CNS disorders |
| 03/09/2005 | CN1592645A Combination therapy for treatment of autoimmune diseases using B cell depleting/immunoregulatory anti-body combination |
| 03/09/2005 | CN1592626A Homeostasis-maintaining agents |
| 03/09/2005 | CN1592618A Method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same |
| 03/09/2005 | CN1590408A Preparation technology of globe fish peptide and its medical health care use |
| 03/09/2005 | CN1590396A Picrorhiza total glycoside extract and its application in preparation of liver disease medicine and preparation method |
| 03/09/2005 | CN1590379A New heterocyclic oxime compounds, preparing process and medical composition thereof |
| 03/09/2005 | CN1589906A New oral formulation for 5-HT4 agonists or antagonists |
| 03/09/2005 | CN1589900A Medical health protection use of globe fish glue |
| 03/09/2005 | CN1589881A Chinese medicinal prescription for treating gastropathy |
| 03/09/2005 | CN1589868A Oral liquid for preventing and treating diarrhea |
| 03/09/2005 | CN1589862A Hepatitis B abdominal distension external plaster and its making method |
| 03/09/2005 | CN1589858A New use of cimicifuga root and its affective part monomer in treating hepatitis B and its preparation method |
| 03/09/2005 | CN1589853A Compound preparation for treating mucosa ulceration |
| 03/09/2005 | CN1589843A Tooth suppository and its proparation method |
| 03/09/2005 | CN1589840A Traditional Chinese medicinal tincture and its preparation method |
| 03/09/2005 | CN1589838A Traditional Chinese medicine for treating stomatitis |
| 03/09/2005 | CN1589834A Liver safeguarding pill |
| 03/09/2005 | CN1589825A Medicine for enriching kidney and nourishing liver |
| 03/09/2005 | CN1589816A Disinfactant tumour decomposition powder |
| 03/09/2005 | CN1589808A Medicinal composition for treating peptic ulcer or enteritis and its preparation process and use |
| 03/09/2005 | CN1589804A Chinese medicine extract for treating fatty liver, obesity and its preparation method |
| 03/09/2005 | CN1589793A Application of tannic acid berberine in preparation of medicine for treating ulcero colonitis |
| 03/09/2005 | CN1589792A Medicinal composition for treating hepatitis and aurigo |
| 03/09/2005 | CN1589780A Limonene soft capsule |
| 03/09/2005 | CN1589778A Microencapsulated saccharomyces and its application |
| 03/09/2005 | CN1589777A Microencapsulated saccharomyces and its application |
| 03/09/2005 | CN1589776A Microencapsulated saccharomyces and its application |
| 03/09/2005 | CN1589774A Slow release medicine for treating alveolysis |
| 03/09/2005 | CN1192032C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 03/09/2005 | CN1192021C 3-azabicyclo [3.1.0] hexane derivatives as opiate receptors ligands |
| 03/09/2005 | CN1192015C Cell adhesion inhibitors |
| 03/09/2005 | CN1191863C Formulations for protection of PEG-alpha interferon conjugates |
| 03/09/2005 | CN1191860C Method for treatment of fibrosis using antagonist of integrin alpha-4 subunit |
| 03/09/2005 | CN1191848C Chinese medicine prepn for treating throat and oral cavity diseases and its prepn process |
| 03/09/2005 | CN1191847C Medicated pillow its making process |
| 03/09/2005 | CN1191846C Medicine for treating stomach disease |
| 03/09/2005 | CN1191844C Smelling treated Chinese medicine |
| 03/09/2005 | CN1191843C Active full-component wheat spear extract and its microcapsule and preparing process |
| 03/09/2005 | CN1191842C Medicine for treating gastroenteritic diseases |
| 03/09/2005 | CN1191833C Remedies for periodontosis |
| 03/08/2005 | US6864368 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases |
| 03/08/2005 | US6864355 Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain |
| 03/08/2005 | US6864291 Agonists specific for the peripheral cannabinoid receptor |
| 03/08/2005 | US6864287 Cardiovascular disorders; hypotensive agents |
| 03/08/2005 | US6864282 9,11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma |
| 03/08/2005 | US6864277 Brain diosrders; cardiovascular disorders; central nervous system disorders; psychological disorders |
| 03/08/2005 | US6864273 Dyspepsia; gastrointestinal disorders; irritable bowel disorders |
| 03/08/2005 | US6864266 4-piperidinyl alkyl amine derivatives as muscarinic receptor antagonists |
| 03/08/2005 | US6864263 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy |
| 03/08/2005 | US6864252 Treatment of cyclooxygenase mediated diseases, such as arthritis, neurodegeneration and colon cancer |
| 03/08/2005 | US6864241 Amine salt of lignan compounds |
| 03/08/2005 | US6863903 Pharmaceutical product comprising anti-secretory protein from egg yolk |
| 03/08/2005 | CA2351848C Method for increasing pet activity |
| 03/08/2005 | CA2100212C Use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura |
| 03/03/2005 | WO2005019268A1 Novel antibody against cancer antigen |
| 03/03/2005 | WO2005019245A1 Heptadepsin |
| 03/03/2005 | WO2005019244A1 Peptides which can bind to transforming growth factor beta 1 (tgf-beta1) |
| 03/03/2005 | WO2005019188A1 Fused pyrimidine derivative and use thereof |
| 03/03/2005 | WO2005018655A1 Use of noni in relation to oral pathologies, for example, in order to combat problems associated with asialia and hyposialia |
| 03/03/2005 | WO2005018654A1 Use of enrerococcus faecium strains for curing hepatic insufficiency and for regenerating and intensifying metabolism in a liver |
| 03/03/2005 | WO2005018648A1 (20S)-1α-HYDROXY-2-METHYLENE-19-NOR-VITAMIN D3 AND ITS USES |
| 03/03/2005 | WO2005018640A1 Kit for treatment of upper gastrointestinal tract conditions |
| 03/03/2005 | WO2005018627A1 Alpha-aminoamide derivatives useful as anti-inflammatory agents |
| 03/03/2005 | WO2005018342A1 Compositions and methods for the maintenance of oral health |
| 03/03/2005 | WO2005000285A3 METHODS OF TREATING NON-INFLAMMATORY GASTROINTESTINAL TRACT DISORDERS USING Cav2.2 SUBUNIT CALCIUM CHANNEL MODULATORS |
| 03/03/2005 | WO2004110466A3 Pediocin-producing pediococci |
| 03/03/2005 | WO2004087701A8 Cyclic benzimidazoles |
| 03/03/2005 | WO2004087054A3 Methods for modulating gastric secretion using prokineticin receptor antagonists. |
| 03/03/2005 | WO2004001058A3 Transcription factor modulating compounds and methods of use thereof |
| 03/03/2005 | WO2003045317A3 Therapeutic protein and treatments |
| 03/03/2005 | US20050050589 Soya cell strains with high isoflavone content |
| 03/03/2005 | US20050049424 6-Hydroxy isoflavones derivatives and medicaments involving same |
| 03/03/2005 | US20050049416 Preparing renzapride (hydrochloride) on a laboratory or industrial scale by a simplified process of forming the acyl chloride derivative of 2-(methoxy),3-acyamino,5-chlorobenzoic acid by reacting oxalyl or thionyl chloride in a solvent, e.g. dimethylformamide; coupling with 1-diazabicylo(3.3.1)nonane |
| 03/03/2005 | US20050049303 Adamantane derivatives |
| 03/03/2005 | US20050049298 pH controlled aqueous solvent extraction from plant material of carboxylic acid form; salt formation and extraction into organic solvent; decarboxylation; filtration and/or chromatographic purification |
| 03/03/2005 | US20050049293 Increasing effect of released acetylcholine on hepatic muscarinic receptors |
| 03/03/2005 | US20050049292 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression |
| 03/03/2005 | US20050049282 Process |